Lisa Herron-Olson | Managing Director
Syntiron

Lisa Herron-Olson is the Managing Director at Syntiron, a leading vaccine biotechnology company specializing in novel bacterial vaccines. With over 20 years of experience in research and development, and a proven track record of strategic partnering and funding innovation, Lisa embodies the resilience that is required to develop vaccines for AMR pathogens. Her leadership has been instrumental in enabling Syntiron to deeply investigate the scientific foundation of its protein vaccine candidates, building a protein antigen development platform that is positioned to reinvigorate the development pipeline for accessible and affordable AMR vaccines.